<DOC>
	<DOC>NCT01904721</DOC>
	<brief_summary>This is a safety and efficacy study of bimatoprost in male subjects with androgenic alopecia (AGA).</brief_summary>
	<brief_title>A Safety and Efficacy Study of Bimatoprost in Men With Androgenic Alopecia (AGA)</brief_title>
	<detailed_description />
	<mesh_term>Alopecia</mesh_term>
	<mesh_term>Alopecia Areata</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Bimatoprost</mesh_term>
	<criteria>Mild to moderate male pattern baldness (androgenic alopecia) with ongoing hair loss for at least 1 year Willingness to maintain same hair style, length and hair color during study Willingness to have microdottattoo applied to scalp (Stage 2 only) Drug or alcohol abuse within 12 months HIV positive Received hair transplants or had scalp reductions Use of hair weaves, hair extensions or wigs within 3 months Use of minoxidil (oral or topical) and/or low level light treatment "combs" for hair growth within the last 6 months, or expected use during the study Application of topical steroids or nonsteroidal antiinflammatory drugs (NSAIDs) to scalp within 4 weeks</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>49 Years</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>